HLA-DRA Antibody (C-term) Blocking Peptide

Produktübersicht

• Artikelname: HLA-DRA Antibody (C-term) Blocking Peptide
• Artikelnummer: ABT-BP6799B
• Hersteller Artikelnummer: BP6799b
• Alternativnummer: ABT-BP6799B-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: HLA class II histocompatibility antigen, DR alpha chain, MHC class II antigen DRA, HLA-DRA, HLA-DRA1

Produktbeschreibung

HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages).

Produkteigenschaften

• NCBI: 3122
• UniProt: P01903
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP6799b was selected from the C-term region of human HLA-DRA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.